About this bill
MPs push to adjust Norway's pharmaceutical cost-effectiveness threshold
Five MPs have proposed adjusting the cost-effectiveness threshold used to evaluate new medicines in Norway's health service. The proposers argue that the threshold has not been revised since 2015, and that a recent report from the Norwegian Medicines Agency does not provide sufficient grounds to reject an adjustment, despite the report's conclusion against one. They contend that raising the threshold to reflect price growth from 2016 to 2025 would have a minimal impact on pharmaceutical budgets.